[HTML][HTML] COVID-19 biomarkers at the crossroad between patient stratification and targeted therapy: the role of validated and proposed parameters

M Rizzi, D D'Onghia, S Tonello, R Minisini… - International Journal of …, 2023 - mdpi.com
Clinical knowledge about SARS-CoV-2 infection mechanisms and COVID-19
pathophysiology have enormously increased during the pandemic. Nevertheless, because …

Prospective selected biomarkers in COVID-19 diagnosis and treatment

T Tabassum, A Rahman, Y Araf, MA Ullah… - Biomarkers in …, 2021 - Taylor & Francis
COVID-19 has become a global health concern, due to the high transmissible nature of its
causal agent and lack of proper treatment. Early diagnosis and nonspecific medical supports …

[HTML][HTML] Biomarkers during COVID-19: mechanisms of change and implications for patient outcomes

CH Chen, SW Lin, CF Shen, KS Hsieh, CM Cheng - Diagnostics, 2022 - mdpi.com
As the COVID-19 (Coronavirus disease 19) pandemic spreads worldwide, the massive
numbers of COVID-19 patients have created a considerable healthcare burden for every …

[HTML][HTML] Laboratory Biomarkers for the Diagnosis and Management of Patients with COVID-19: an Updated Review

BB Li, SJ Huang, YL Fu, ZL Li, J Wang… - Discovery …, 2021 - discoverymedicine.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become a global crisis
due to strong infectivity and fast transmission speed. Some patients with Coronavirus …

Molecular markers for early stratification of disease severity and progression in COVID-19

A Kashyap, SA Sebastian… - Biology Methods and …, 2022 - academic.oup.com
COVID-19 infections have imposed immense pressure on the healthcare system of most
countries. While the initial studies have identified better therapeutic and diagnostic …

[HTML][HTML] Blood-based biomarkers for diagnosis, prognosis, and severity prediction of COVID-19: Opportunities and challenges

R Mittal, N Chourasia, VK Bharti, S Singh… - Journal of Family …, 2022 - journals.lww.com
The reasons for high morbidity and mortality with Corona virus disease (COVID-19) disease
remain unanswered with extremes of manifestation and uncertainty of modes of …

[HTML][HTML] COVID19 biomarkers: What did we learn from systematic reviews?

S Semiz - Frontiers in cellular and infection microbiology, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

Comorbidities influence the predictive power of hematological markers for mortality in hospitalized COVID-19 patients

A Parthasarathi, CK Basavaraja, S Arunachala… - … in Respiratory Medicine, 2022 - mdpi.com
Abstract Introduction: Coronavirus disease 2019 (COVID-19) pandemic has caused
unprecedented mortality and has stretched the health infrastructure thin worldwide …

[HTML][HTML] Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients

RM Elshazli, EA Toraih, A Elgaml, M El-Mowafy… - PloS one, 2020 - journals.plos.org
Objective Evidence-based characterization of the diagnostic and prognostic value of the
hematological and immunological markers related to the epidemic of Coronavirus Disease …

[HTML][HTML] Hematological-and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases

R Suárez-Del-Villar-Carrero… - Journal of Clinical …, 2022 - mdpi.com
COVID-19 has overloaded health system worldwide; thus, it demanded a triage method for
an efficient and early discrimination of patients with COVID-19. The objective of this research …